September 24: The Week in Cancer News
Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and more news of the week from Cancer Today.
Progress Against Cancer
Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and more news of the week from Cancer Today.
With targeted drugs, immunotherapies and treatment combinations now available, people with advanced melanoma have choices to make.
Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
Researchers create breast cancer prediction models tailored for Asian Americans.
High-grade glioma, a kind of brain tumor, is difficult to treat and often fatal in children and adolescents.
Liquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
KRAS mutations were once thought to be resistant to drug therapy.
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected by vaccines. Blood Cancer Discovery, a journal of the American Association for Cancer Research (AACR), has recently published studies investigating the...
9/11 first responders’ cancer survival compares favorably to the general population, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 49,000 members worldwide drive progress against cancer.
Donate Now